TBH Global Asset Management LLC Has $836,000 Stake in UnitedHealth Group Incorporated (NYSE:UNH)

TBH Global Asset Management LLC cut its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 32.7% during the 4th quarter, HoldingsChannel reports. The fund owned 1,588 shares of the healthcare conglomerate’s stock after selling 771 shares during the quarter. TBH Global Asset Management LLC’s holdings in UnitedHealth Group were worth $836,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Richelieu Gestion SA purchased a new position in shares of UnitedHealth Group in the 4th quarter valued at approximately $26,000. CGC Financial Services LLC raised its holdings in UnitedHealth Group by 1,000.0% in the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after acquiring an additional 50 shares during the last quarter. LFA Lugano Financial Advisors SA lifted its position in shares of UnitedHealth Group by 148.1% during the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after purchasing an additional 40 shares in the last quarter. O Brien Wealth Partners LLC boosted its position in UnitedHealth Group by 36.8% during the 4th quarter. O Brien Wealth Partners LLC now owns 78 shares of the healthcare conglomerate’s stock valued at $41,000 after purchasing an additional 21 shares during the period. Finally, Friedenthal Financial acquired a new position in UnitedHealth Group in the fourth quarter worth approximately $42,000. 87.86% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of research firms have commented on UNH. Wells Fargo & Company reduced their price objective on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating on the stock in a research note on Monday, April 8th. Stephens restated an “overweight” rating and issued a $605.00 price objective on shares of UnitedHealth Group in a research note on Thursday, February 8th. Royal Bank of Canada dropped their target price on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating for the company in a research report on Wednesday, April 17th. Truist Financial reissued a “buy” rating and issued a $600.00 target price on shares of UnitedHealth Group in a research note on Wednesday, April 17th. Finally, Barclays increased their target price on UnitedHealth Group from $534.00 to $560.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 17th. Three research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $570.05.

Insider Activity

In related news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.33% of the stock is owned by corporate insiders.

UnitedHealth Group Stock Performance

UNH stock traded down $8.66 on Friday, hitting $508.17. The company’s stock had a trading volume of 2,414,748 shares, compared to its average volume of 4,167,892. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $554.70. The firm has a 50 day moving average of $488.88 and a two-hundred day moving average of $511.10. The stock has a market cap of $467.71 billion, a price-to-earnings ratio of 31.43, a price-to-earnings-growth ratio of 1.51 and a beta of 0.55. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. During the same quarter in the prior year, the business earned $6.26 earnings per share. The company’s revenue was up 8.6% compared to the same quarter last year. Equities analysts predict that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.